BCR-ABL1 H396P
|
CML
|
BCR-ABL1 H396P
|
CML
|
nilotinib Sensitive: C4 – Case Studies
|
nilotinib Sensitive: C4 – Case Studies
|
BCR-ABL1 H396P
|
CML
|
BCR-ABL1 H396P
|
CML
|
bosutinib Sensitive: D – Preclinical
|
bosutinib Sensitive: D – Preclinical
|
BCR-ABL1 H396P
|
CML
|
BCR-ABL1 H396P
|
CML
|
ponatinib Sensitive: D – Preclinical
|
ponatinib Sensitive: D – Preclinical
|
BCR-ABL1 H396P
|
CML
|
BCR-ABL1 H396P
|
CML
|
dasatinib Sensitive: D – Preclinical
|
dasatinib Sensitive: D – Preclinical
|